Skip to content Skip to footer
Aflibercept: Benefits, Reviews, Info, Side Effects!
Rx Details
Aflibercept
Zaltrap, Eylea
Aflibercept
Prescription
Medication
Drugs
Prescription Only
treatment of wet age-related macular degeneration, treatment of diabetic macular edema, treatment of macular edema following retinal vein occlusion, treatment of diabetic retinopathy, reduction of vision loss, improvement of visual acuity
Blurred Vision, Cataracts, Dry Eyes, Eye Irritation, Eye Pain, Feeling Of Having Something In The Eye, Floaters In Vision, Headache, Increased Eye Pressure, Redness In The Eye, Sensitivity To Light, Watery Eyes
Aflibercept is a medication used primarily in the treatment of certain eye conditions, such as age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion. It is administered as an intravitreal injection directly into the eye. The typical dosage of aflibercept for these conditions is: – **For neovascular (wet) age-related macular degeneration (AMD):** The usual dose is 2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 3 months, followed by 2 mg (0.05 mL) once every 8 weeks (2 months). – **For diabetic macular edema (DME) and diabetic retinopathy:** The typical dose is 2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 5 injections, followed by 2 mg (0.05 mL) once every 8 weeks (2 months). – **For macular edema following retinal vein occlusion (RVO):** The usual dose is 2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly). It’s important to note that the exact dosage and frequency may vary based on the specific condition being treated and the patient’s response to the medication. Therefore, it is crucial to follow the prescribing physician’s instructions and recommendations.
Age-related macular degeneration, diabetic macular edema, central retinal vein occlusion, branch retinal vein occlusion, diabetic retinopathy
Generally well-tolerated with common side effects including hypertension and proteinuria.
No Interactions Reported
$1,000 – $2,000
$1,500 per dose.

A Synopsis of

Aflibercept

Aflibercept is a medication that is commonly used in the treatment of certain types of cancer, particularly colorectal cancer and certain eye conditions such as macular degeneration. It belongs to a class of drugs known as vascular endothelial growth factor (VEGF) inhibitors, which work by blocking the growth of blood vessels that supply nutrients to tumors or abnormal blood vessels in the eye.

In the treatment of colorectal cancer, Aflibercept is often used in combination with other chemotherapy medications to help slow down the growth and spread of cancer cells. It can also be used to treat certain eye conditions by reducing the abnormal blood vessel growth that can lead to vision loss.

As with any medication, there are potential side effects associated with Aflibercept. These can include high blood pressure, protein in the urine, and gastrointestinal issues such as diarrhea or constipation. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment with Aflibercept.

Overall, Aflibercept has been shown to be an effective treatment option for certain types of cancer and eye conditions. It is important to follow your healthcare provider’s instructions carefully and attend all scheduled appointments to monitor your progress while taking this medication. If you have any questions or concerns about Aflibercept or its use in your treatment plan, do not hesitate to reach out to your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN